For much of the last decade, it has felt as though Icelandic warrior-sprite Bjork has placed greater value on innovation and experimentalism than on creating compelling, enjoyable music. It's a trend that began with 2004's Medulla, with its a cappella construction and single-minded focus; it continued with 2007's Volta and 2011's Biophilia, albums that positioned themselves at the vanguard with omnivorous energy and cutting-edge rollouts.

Subscribe to billboard biz to continue reading this article and thousands more. subscribers get:
  • 24/7 coverage of every genre and sector of the business with over 150 exclusive charts
  • Bulletin: Breaking stories, chart info and analysis sent directly to your inbox every weekday
  • Billboard Magazine iPad Edition: An enhanced version of the magazine with video, photo galleries and playable charts
  • Archives: A rich history of articles and exclusive charts

Join now or Log In